Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
News
July 22, 2024
Clinical Trials Arena reports that Lexicon will work with Medidata to progress their Phase IIb of LX9211 study, leading to the first new drug to be approved for diabetic peripheral neuropathy in more than 20 years.